GAITHERSBURG, Md., Feb. 12, 2015 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) will host a conference call on Thursday, March 5, 2015 at 5:00 pm (Eastern Time) to discuss the financial results for the fourth quarter and full twelve months of 2014, recent business developments, financial outlook for full year 2015, and revenue guidance for the first quarter of 2015.
This conference call can be accessed live by telephone or through Emergent's website:
|Live Teleconference Information:||Live Webcast Information:|
|Dial in number: 888-680-0878||Visit www.emergentbiosolutions.com|
|(International dial in: 617-213-4855)||and select the "Investors" section|
Pre-registering for the live call will expedite access and minimize hold times. You will be issued a passcode to bypass the operator and connect directly. To pre-register for the call, visit the following website: https://www.theconferencingservice.com/prereg/key.process?key=PAM77UU4L.
About Emergent BioSolutions Inc.
Emergent BioSolutions is a specialty biopharmaceutical company seeking to protect and enhance life by offering specialized products to healthcare providers and governments to address medical needs and emerging health threats. Additional information about us may be found at www.emergentbiosolutions.com.
Follow us on twitter: @emergentbiosolu.
CONTACT: Investors Contact: Robert G. Burrows Vice President, Investor Relations 240-631-3280 BurrowsR@ebsi.com Media Contact: Tracey Schmitt Vice President, Global Public Affairs and Corporate Responsibility 240-631-3200 SchmittT@ebsi.com
Source:Emergent BioSolutions Inc.